117 related articles for article (PubMed ID: 2793995)
1. The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride.
Hodsman AB; Drost DJ
J Clin Endocrinol Metab; 1989 Nov; 69(5):932-8. PubMed ID: 2793995
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
[TBL] [Abstract][Full Text] [Related]
3. Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate.
Ringe JD; Kipshoven C; Cöster A; Umbach R
Osteoporos Int; 1999; 9(2):171-8. PubMed ID: 10367046
[TBL] [Abstract][Full Text] [Related]
4. Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis.
Crilly RG; Sebaldt RJ; Hodsman AB; Adachi JD; Brown JP; Goldsmith CH; Hanley DA; Olszynski WO; Ste-Marie LG; Stephenson GF
Osteoporos Int; 2000; 11(7):607-14. PubMed ID: 11069195
[TBL] [Abstract][Full Text] [Related]
5. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis.
Riggs BL; O'Fallon WM; Lane A; Hodgson SF; Wahner HW; Muhs J; Chao E; Melton LJ
J Bone Miner Res; 1994 Feb; 9(2):265-75. PubMed ID: 8140940
[TBL] [Abstract][Full Text] [Related]
7. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
Delmas PD; Dupuis J; Duboeuf F; Chapuy MC; Meunier PJ
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women.
Miller PD; Neal BJ; McIntyre DO; Yanover MJ; Anger MS; Kowalski L
Osteoporos Int; 1991 Jun; 1(3):171-6. PubMed ID: 1790405
[TBL] [Abstract][Full Text] [Related]
9. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements.
Nagant de Deuxchaisnes C; Devogelaer JP; Depresseux G; Malghem J; Maldague B
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S5-26. PubMed ID: 2187327
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
11. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
12. [Comparative effects of sodium fluoride and hormonal replacement therapy on bone metabolism in osteoporotic women with high fracture risk. Results of monitoring for 2 years].
Pouillès JM; Trémollières F; Ribot C
Rev Rhum Mal Osteoartic; 1992 Feb; 59(2):103-13. PubMed ID: 1604221
[TBL] [Abstract][Full Text] [Related]
13. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.
Pak CY; Sakhaee K; Zerwekh JE; Parcel C; Peterson R; Johnson K
J Clin Endocrinol Metab; 1989 Jan; 68(1):150-9. PubMed ID: 2909549
[TBL] [Abstract][Full Text] [Related]
14. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
[TBL] [Abstract][Full Text] [Related]
16. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
[TBL] [Abstract][Full Text] [Related]
17. Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response.
Murray TM; Harrison JE; Bayley TA; Josse RG; Sturtridge WC; Chow R; Budden F; Laurier L; Pritzker KP; Kandel R
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S27-35. PubMed ID: 2339633
[TBL] [Abstract][Full Text] [Related]
18. Fluoride therapy in postmenopausal osteopenic women: effect on vertebral and femoral bone density and prediction of bone response.
Pouilles JM; Tremollieres F; Causse E; Louvet JP; Ribot C
Osteoporos Int; 1991 Feb; 1(2):103-9. PubMed ID: 1790390
[TBL] [Abstract][Full Text] [Related]
19. Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study.
Zanchetta JR; Bogado CE; Cisari C; Aslanidis S; Greisen H; Fox J; Lems W
Curr Med Res Opin; 2010 Nov; 26(11):2627-33. PubMed ID: 20923256
[TBL] [Abstract][Full Text] [Related]
20. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
Reeve J; Davies UM; Hesp R; McNally E; Katz D
BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
